A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Aflibercept (Primary) ; Fludeoxyglucose F-18; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 15 Sep 2017 Planned primary completion date changed from 1 Sep 2017 to 31 Dec 2017.
- 10 Jun 2017 Biomarkers information updated
- 14 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.